LifeStance Health Group (LFST) Cash Flow: Operating & Free Cash Flow

LifeStance Health Group Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for LifeStance Health Group, Inc. (LFST) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Operating Activities
Net Income	9.66	-57.44	-186.26	-215.56	-307.20	-38.07	5.67
Depreciation & Amortization	54.75	70.95	80.44	69.20	54.14	31.05	6.10
Deferred Income Tax	2.42	-0.96	-21.92	-16.73	-26.95	0.00	1.76
Stock Based Compensation	74.70	76.17	99.39	187.43	259.44	1.45	0.05
Change in Working Capital	-40.34	-27.37	-33.72	-16.94	2.14	-0.75	2.99
Change in Accounts Receivable	36.09	-6.40	-24.18	-21.66	-24.21	-13.31	-5.76
Change in Accounts Payable	-1.56	0.50	-5.61	7.67	0.62	0.83	2.54
Change in Other Working Capital	-74.87	-50.08	-40.63	-2.94	13.41	11.72	6.22
Other Operating Activities	44.96	44.95	23.28	45.40	13.41	-3.18	0.48
Net Cash from Operating Activities	146.15	107.26	-16.88	52.79	9.42	-8.53	17.05
Investing Activities
Capital Expenditures	-36.13	-21.57	-40.52	-79.26	-94.49	-38.07	-14.31
Acquisitions	0.00	0.00	-19.82	-60.21	-99.58	-823.10	-59.06
Net Cash from Investing Activities	-36.13	-21.57	-60.34	-139.46	-194.08	-861.17	-73.38
Financing Activities
Debt Repayment	-7.25	-289.49	-2.47	69.56	-311.39	291.41	55.45
Common Stock Issued	0.00	0.00	0.00	0.00	549.91	654.59	0.00
Common Stock Repurchased	0.00	0.00	0.00	-0.90	0.00	-1.00	0.00
Other Financing Activities	-8.71	-8.26	-7.86	-21.39	-23.46	-32.72	-6.99
Net Cash from Financing Activities	-15.96	-9.95	47.43	47.26	313.86	912.27	48.46
Summary
Effect of Forex Changes on Cash	0.00	0.00	0.00	0.00	0.00	-27.22	0.00
Net Change in Cash	94.07	75.75	-29.80	-39.41	129.20	42.57	-7.86
Cash at Beginning of Period	154.57	78.82	108.62	148.03	18.83	3.48	11.35
Cash at End of Period	248.64	154.57	78.82	108.62	148.03	18.83	3.48
Free Cash Flow	110.03	85.69	-57.40	-26.47	-85.07	-46.60	2.73
Supplemental Disclosures
Interest Paid	-	-	-	-	-	17.15	-
Income Taxes Paid	-	0.06	0.08	2.24	1.09	0.25	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About LifeStance Health Group Cash Flow

What is LifeStance Health Group's free cash flow?

LifeStance Health Group generated free cash flow of $110.03M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $146.15M minus $36.13M of capital expenditures. That was up 28.4% from $85.69M a year earlier. Free cash flow equaled 7.7% of revenue.

How much does LifeStance Health Group spend on capital expenditures?

LifeStance Health Group spent $36.13M on capital expenditures in fiscal 2025, compared with $21.57M a year earlier. That equals 24.7% of operating cash flow.

Does LifeStance Health Group pay dividends or buy back shares?

LifeStance Health Group's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition